Chargement en cours...
O(6)-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma
BACKGROUND: Treatment of glioblastoma (GB), the most common malignant primary brain tumor in adults, can include alkylating chemo-therapeutic agents. Two molecular biomarkers of treatment response are MGMT (O(6)-methylguanine-DNA methyltransferase) promoter methylation and IDH (isocitrate dehydrogen...
Enregistré dans:
| Publié dans: | Ann Saudi Med |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
King Faisal Specialist Hospital and Research Centre
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894451/ https://ncbi.nlm.nih.gov/pubmed/31804140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5144/0256-4947.2019.410 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|